Form 4 holding
Chief Medical Officer
Amylyx Pharmaceuticals, Inc.
- Security class
- Common Stock
- Shares / value
- 205,605
- Estimated value
- $3,357,139
- Report date
- 09 Jan 2024
- Price
- $16.33
- Ownership
- Direct
Patrick D. Yeramian - Chief Medical Officer at Amylyx Pharmaceuticals, Inc.
Issuer-level insider activity
- Role
- Chief Medical Officer
- Issuer ticker
- AMLX on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Patrick D. Yeramian since 13 Sep 2025
Reported holdings for Patrick D. Yeramian in Amylyx Pharmaceuticals, Inc.
Form 4 holding
Chief Medical Officer
Amylyx Pharmaceuticals, Inc.
- Security class
- Stock Option (right to buy)
- Shares / value
- 33,770
- Estimated value
- Report date
- 15 May 2023
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Patrick D. Yeramian in Amylyx Pharmaceuticals, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.